Date Hour Room Track
05th December,2018 14:00-15:30 Track 3

Prior to engaging a non-dilutive financing strategy, it is essential to recognise that this money is not necessarily “free” and potential company founders should carefully assess the costs, and other pros and cons of each potential funding source. In this session, we will wonder whether non-dilutive financing alternatives create hidden dangers, and what the actual conditions and requirements of the emerging players are at the initial stages of funding.

Anjan ARALIHALLI - CTI Life Sciences Fund II

Continue your tour